These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
244 related items for PubMed ID: 25684486
21. Immunohistochemical staining with deltaNp63 is useful for distinguishing the squamous cell component of adenosquamous cell carcinoma of the lung. Uramoto H, Yamada S, Hanagiri T. Anticancer Res; 2010 Nov; 30(11):4717-20. PubMed ID: 21115930 [Abstract] [Full Text] [Related]
25. MET Gene Amplification and Overexpression in Chinese Non-Small-Cell Lung Cancer Patients Without EGFR Mutations. Song Z, Wang X, Zheng Y, Su H, Zhang Y. Clin Lung Cancer; 2017 Mar; 18(2):213-219.e2. PubMed ID: 28322191 [Abstract] [Full Text] [Related]
28. [Detection of epidermal growth factor receptor mutations in non-small-cell lung carcinoma by direct sequencing and correlations with clinicopathological characteristics and sample types]. Sun MH, Yang F, Shen L, Zhang L, Chen Y, Cai X, Zhu XL, Zhou XY. Zhonghua Bing Li Xue Za Zhi; 2011 Oct; 40(10):655-9. PubMed ID: 22321541 [Abstract] [Full Text] [Related]
29. The efficacy of EGFR gene mutation testing in various samples from non-small cell lung cancer patients: a multicenter retrospective study. Krawczyk P, Ramlau R, Chorostowska-Wynimko J, Powrózek T, Lewandowska MA, Limon J, Wasąg B, Pankowski J, Kozielski J, Kalinka-Warzocha E, Szczęsna A, Wojas-Krawczyk K, Skroński M, Dziadziuszko R, Jaguś P, Antoszewska E, Szumiło J, Jarosz B, Woźniak A, Jóźwicki W, Dyszkiewicz W, Pasieka-Lis M, Kowalski DM, Krzakowski M, Jassem J, Milanowski J. J Cancer Res Clin Oncol; 2015 Jan; 141(1):61-8. PubMed ID: 25086987 [Abstract] [Full Text] [Related]
31. Prevalence and Clinical Profile of EGFR Mutation In Non- Small-Cell Lung Carcinoma Patients in Southwest China. Zhou J, Song XB, He H, Zhou Y, Lu XJ, Ying BW. Asian Pac J Cancer Prev; 2016 Jan; 17(3):965-71. PubMed ID: 27039821 [Abstract] [Full Text] [Related]
33. Using whole genome amplification (WGA) of low-volume biopsies to assess the prognostic role of EGFR, KRAS, p53, and CMET mutations in advanced-stage non-small cell lung cancer (NSCLC). Lim EH, Zhang SL, Li JL, Yap WS, Howe TC, Tan BP, Lee YS, Wong D, Khoo KL, Seto KY, Tan L, Agasthian T, Koong HN, Tam J, Tan C, Caleb M, Chang A, Ng A, Tan P. J Thorac Oncol; 2009 Jan; 4(1):12-21. PubMed ID: 19096301 [Abstract] [Full Text] [Related]